ursodeoxycholic acid), demonstrate limited efcacy and carry risks of
adverse effects, underscoring the need for safer alternatives. This ther-
apeutic gap has intensied interest in natural bioactive compounds with
multimodal hepatoprotective properties.
Polysaccharides represent a promising class of phytochemicals
exhibiting potent antioxidant, anti-inammatory, and immunomodula-
tory activities [9]. Some polysaccharides extracted from Angelica sinensis
[10], Enteromorpha prolifera [11], and Dendrobium ofcinale [12]
demonstrated anti-AALI activity. Dendrobium huoshanense poly-
saccharides could mitigate early-stage steatosis and inammation in
AALI by modulating the fatty acid metabolism pathway [13]. Dioscoreae
Rhizoma (Dioscorea opposite Thunb.), also known as Chinese yam (CY),
has been a resourceful food for gastrointestinal protection on a global
scale [14]. It has boasted numerous biological activities, such as the
strengthening of immunity, gastrointestinal protection, antioxidation,
anti-tumor, and so on [15]. Earlier literature has shown that yam gruel
can regulate hepatic lipid metabolism disorders by activating the
AMPK/ACC/CPT-1 pathway in diabetic rats [16]. Polysaccharides,
which are among the most prevalent active ingredients in CY, have been
shown to reduce oxidative, inammatory, and anti-hyperglycaemic ef-
fects [17]. However, as a widely used resource plant, the hep-
atoprotective effect of Dioscoreae Rhizoma polysaccharide (CP) has not
been specically studied.
This study investigates the therapeutic efcacy of a novel acidic
polysaccharide from Dioscoreae Rhizoma (CP-2) in AALI models.
Through a comprehensive analysis of ethanol metabolism biomarkers,
oxidative-inammatory markers, lipid-regulatory proteins, and gut
microbiota proles, we elucidate CP-2's mechanistic role in hep-
atoprotection. This research could form the basis for the formulation and
use of CP-2 in food and medical applications.
2. Materials and methods
2.1. Materials and reagents
Anhydrous ethanol (analytical grade) was procured from Shanghai
Titan Scientic Co., Ltd. (Shanghai, China). Bifendate pills (batch
number: 230703) were sourced from Beijing Union Pharmaceutical
Factory Ltd. (Beijing, China). DEAE-52, catalase (CAT), malondialde-
hyde (MDA), superoxide dismutase (SOD), and Ethanol Assay Kit were
obtained from Beijing Solarbio Science & Technology Co., Ltd. (Beijing,
China). Alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase
(ALDH), triglyceride (TG), alanine aminotransferase (ALT), and aspar-
tate aminotransferase (AST) kits were acquired from Nanjing Jiancheng
Bioengineering Institute (Nanjing, China). Lipopolysaccharide (LPS),
cytochrome P450 family 2 subfamily E member 1 (CYP
2
E
1
), Interleukin
1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor-
α
(TNF-
α
)
ELISA kits were purchased from Hunan Aifang Biotechnology Co., Ltd.
(Changsha, China).
2.2. The preparation of crude polysaccharide (CCP)
The Chinese yam was supplied by Jiaozuo Mingren Natural Medicine
Co., Ltd. (Jiaozuo, China). CP was prepared via hot water extraction and
ethanol precipitation [18]. Briey, 1,000 g of crushed and sieved raw
materials were mixed with 10 L of distilled water and heated at 100 ◦C
for 1 h. The residue underwent two additional extractions under iden-
tical conditions. The ltrates were then concentrated to 1 L and
precipitated using 80 % ethanol. The precipitate was re-dissolved,
deproteinized using a mixture of chloroform (purity 99.0 %) and n-
butanol (purity 99.5 %) in a 5:1 volume ratio, decolorized by the acti-
vated carbon (Macklin Co., Ltd., Beijing, China), dialyzed (3.5 kDa
MWCO membrane, Beijing Solarbio Science & Technology Co., Ltd.,
Beijing, China), and lyophilized to obtain the crude polysaccharide
(CCP, yield 0.5 %).
2.3. The isolation and purication of CP
CP was subjected to isolation and purication using DEAE-Cellulose
(Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) [19].
Firstly, 50 mg of CCP was dissolved in 1.0 mL of distilled water and
fractionated on the column (50 cm ×2.6 cm). The column was then
eluted with 0, 0.1, 0.3, and 0.5 M NaCl solutions, resulting in the gen-
eration of an elution curve. This curve exhibited three principal peaks,
designated CP-1, CP-2, and CP-3.
2.4. Characterization of CP-2
2.4.1. Chemical composition analysis
Chemical methods were used to determine the total carbohydrate,
protein, and uronic acid content of CP-2 [20–22]. The phenol‑sulfuric
acid method was used to determine the total carbohydrate content of CP-
2. The Coomassie brilliant blue method was used to determine the total
protein content. The m-hydroxydiphenyl colorimetry method was used
to determine the uronic acid content.
2.4.2. CP-2 molecular weight determination
An Agilent 1260 series HPLC equipped with an evaporative light-
scattering detector (ELSD) was used to determine the molecular
weight of CP-2 [21]. Dextran standards of different molecular weights
(China National Institute for the Control of Pharmaceutical and Bio-
logical Products, purity ≥98.0 %) for standard curves. TSK gel GMPWxl
and TSK gel G3000PWxl (Tosoh Corp., Tokyo, Japan) columns were
used for separation at a column temperature of 25 ◦C and a ow rate of
1.0 mL/min. The mobile phase was distilled water using isocratic
elution.
2.4.3. FT-IR spectra determination
CP-2 mixed with potassium bromide powder was used to press mil-
limetre thick sheets. Fourier transform infrared (FT-IR, Shimadzu,
Japan) spectral analysis was performed in the 4000–400 cm
−1
region
[23].
2.4.4. Determination of the composition of CP-2 monosaccharides
CP-2 (5 mg) was dissolved in 2 mL of 3 M triuoroacetic acid, hy-
drolyzed at 120 ◦C for 3 h, and dried with nitrogen gas. The resulting
residue was dissolved in pure water and centrifuged (12,000 rpm, 5
min). Finally, the supernate was used for high-performance anion ex-
change chromatography - pulsed amperometric detector (HPAEC-PAD,
Thermo Fisher ICS5000, USA) analysis [24]. DionexCarbopac™PA20
(150 mm ×3.0 mm) column was used for separation at a column tem-
perature of 30 ◦C and a ow rate of 0.3 mL/min. There were three
mobile phases, including H
2
O (A), 250 mM NaOH (B), and 500 mM
NaOH and 50 mM NaAc (C). Elution gradient: 98 % A: 2 % B at 0–23
min, 80 % A: 20 % B at 23–33 min, 80 % A: 20 % C at 33–46 min, 20 % A:
80 % C at 46–66 min, 98 % A: 2 % B at 66–80 min. Monosaccharide
standards (BoRui Saccharide Biotech Co. Ltd., purity ≥98.0 %) are used
to determine monosaccharide retention times. Take each mono-
saccharide standard solution and accurately congure the mixed stan-
dard solution. According to the absolute quantitative method, the
content of different monosaccharides was determined and the molar
ratio was calculated according to the molar mass of monosaccharides.
2.5. Animals and treatments
2.5.1. Experimental design
Thirty-six male ICR mice (6 weeks old) were obtained from Yangz-
hou University (Jiangsu, China) and fed according to the procedure of
the Animal Ethics Committee of China Pharmaceutical University
(protocol no. 2023–04-011). Mice were housed at room temperature of
25 ±1 ◦C, relative humidity of 45.0 ±5.0 %, and a 12 h light/dark
cycle.
Y. Xie et al.
International Journal of Biological Macromolecules 310 (2025) 143145
2